Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
China National Pharmaceutical Group Corporation
Chinaen.sinopharm.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
State-owned enterprise with approved vaccines and drugs including COVID-19 vaccines (BBIBP-CorV) used globally and various prophylactic vaccines covering over 80% of China's EPI vaccines.
- Therapeutic areas
- NeurologyInfectious Diseases
- Modalities
- Prophylactic vaccineSmall molecule drugLive attenuated vaccineInactivated vaccineCombination vaccine
- Industry
- Pharma
02
Partnerships
Otsuka (China Otsuka Pharmaceutical Co., Ltd.)Janssen (Xian Janssen Pharmaceutical Co., Ltd.)Bristol-Myers Squibb (Sino-American Squibb Pharmaceutical Co., Ltd.)PfizerHua MedicineFosun Pharmaceutical
Beyond the preview
Go deeper on China National Pharmaceutical Group Corporation.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on China National Pharmaceutical Group Corporation.